Key facts
- Clearsense’s last known valuation is $174.0M (Mar 2026).
- It has raised $189.5M across 1 recorded rounds; the latest was Early Stage VC ($5.0M) in Mar 2026.
- Notable investors include UPMC Enterprises, HealthQuest Capital, Caron Capital, Health Catalyst Capital Management, KMMT Capital — 6 tracked in total.
- Clearsense has filed 1 Form D with the SEC, most recently Apr 2026 ($5.0M sold to 8 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Clearsense
Funding rounds
1 roundsAbout Clearsense
Developer of a data platform-as-a-service technology designed to empower data confidence and speed future outcomes. The company's technology converts data into a single source of truth to accelerate data maturity, optimize analytics tools, improve decision quality, and unlock meaningful outcomes, enabling healthcare organizations to utilize the power of disparate data sources to reduce costs, increase revenue opportunities, and improve outcomes.
- Sector
- Healthcare
- HQ
- Brentwood, TN, United States
- Founded
- 2010
- Employees
- 98
- Website
- clearsense.com/
- Ownership
- Privately Held (backing)
Clearsense doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Clearsense shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Clearsense in its N-PORT filings yet. We sweep new filings monthly.